Research Study Search Tool

Use our HBOC Research Search tool to find and participate in research focused on hereditaty cancers. Need assistance getting started?

Search Results: Prevention, Detection & Risk + Risk Reduction (3 results)

Here are some research studies that may be enrolling patients like you. Please check with the study contact and your health care provider to confirm your eligibility and see if the study is right for you. Note, our search tool may not be comprehensive and additional research resources can be found here.

Pilot Study of Denosumab in BRCA1 or BRCA2 Mutation Carriers Scheduling Risk-Reducing Salpingo-Oophorectomy

Prevention:
Ovarian

Pilot Study of Denosumab in BRCA1 or BRCA2 Mutation Carriers Scheduling Risk-Reducing Salpingo-Oophorectomy

The purpose of this study is to evaluate the effects of denosumab on ovarian cancer risk markers among premenopausal women with a BRCA1 or BRCA2 mutation, who are scheduled to undergo risk-reducing surgery to remove their ovaries and fallopian tubes. Denosumab is an FDA-approved injectable medication that is used to treat osteoporosis and to prevent fractures in cancer patients with bone metastases.

The Women Choosing Surgical Prevention (WISP) Trial

Prevention:
Ovarian

Quality of Life:
High Risk But No Cancer

The Women Choosing Surgical Prevention (WISP) Trial

The goal of the WISP Study is to compare whether removal of fallopian tubes only, delaying removal of the ovaries can safely improve sexual functioning and menopausal symptoms compared to standard risk-reducing removal of the ovaries and fallopian tubes (also known as risk-reducing salpingo-oophorectomy or RRSO). You can visit the WISP website for more information.

 

Dose-Response of Aerobic Training in Post-Menopausal Women at High-Risk for Development of Breast Cancer

Prevention:
Breast

Dose-Response of Aerobic Training in Post-Menopausal Women at High-Risk for Development of Breast Cancer

In this study, researchers want to determine the optimal amount of exercise needed to change certain factors associated with breast cancer risk for post-menopausal, high-risk women.

Visit the study website for more information.

Additional Results on Clinicaltrials.gov: Prevention, Detection & Risk + Risk Reduction

24 Results

Clinical Trial Official Title
NCT02068092 Olive Oil for High Risk Breast Cancer Prevention in Women
NCT04201223 Family Lifestyles, Actions, and Risk Education Intervention: Version 2
NCT03069742 Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting
NCT04009148 Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
NCT03762590 GENetic Education Risk Assessment and TEsting Study
NCT03448003 Comprehensive Lifestyle Change To Prevent Breast Cancer
NCT03971591 Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors
NCT03654638 Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer
NCT03837496 Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors
NCT00291096 Protocol for Women at Increased Risk of Developing Breast Cancer
NCT04321135 Avanzando Juntas: Adapting an Evidence Based Weight Loss Program for Hispanic Breast Cancer Survivors
NCT04086875 A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
NCT04064151 A Research Study for Latina Women Undergoing Breast Cancer Treatment
NCT04170712 Data and Specimen Bank of Patients Diagnosed With, and at High-risk for, Gynecologic Cancers
NCT03726619 e-CHEC-uP: Scaling up an Efficacious Cancer Screening Intervention for Women With Limited English
NCT02760849 Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
NCT04051502 ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
NCT03470402 Decision Support for BRCA Testing in Ethnically Diverse Women
NCT02657993 Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence
NCT03961685 Cancer Activity and Lifestyle Measurement Study
NCT04067726 RANKL Inhibition and Mammographic Breast Density
NCT02694809 The PROMISE Study: Duavee in Women With DCIS
NCT02928978 Ruxolitinib for Premalignant Breast Disease
NCT01247597 DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

FORCE:Facing Our Risk of Cancer Empowered